Papers: 10.3389/fcell.2021.690796

https://doi.org/10.3389/fcell.2021.690796

Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma

Cited by: 10
Author(s): Yuanyuan Guo, Beibei Liu, Yihan Liu, Wei Sun, Wuyue Gao, Shilong Mao, Li Chen
Published: about 5 years ago

Software Mentions 1